文献速递头颈外科

腮腺恶性肿瘤患者的生活质量结局

Quality of Life Outcomes for Parotid Malignancies.
PubMed 文献 · Laryngoscope · 2024-06-04

本研究回顾性分析2017至2023年一家多学科头颈癌生存门诊中所有接受手术的恶性腮腺肿瘤患者,采用UW-QOL、EAT-10、PHQ-8、GAD-7、NDI和失眠严重指数等患者报告结局指标,并用多变量回归分析临床预测因素。62例患者中,末次随访时临床相关吞咽困难、抑郁症状升高、中重度焦虑、中重度颈痛及中重度失眠的患病率分别为32.3%、15.5%、7.1%、17.7%和7.2%。辅助放化疗和辅助放疗与更差的患者报告结局相关。

要点

  • 62例手术治疗的恶性腮腺肿瘤患者中,末次随访时临床相关吞咽困难患病率为32.3%。
  • 辅助放化疗患者较单纯手术患者的躯体生活质量、社会情绪生活质量和吞咽评分显著更差。
  • 辅助放化疗患者较辅助放疗患者的吞咽和颈痛显著更差。

核心结论

  • 在接受手术治疗的恶性腮腺肿瘤患者中,辅助放化疗和辅助放疗与更差的患者报告结局相关。

研究设计与样本

  • 本研究为回顾性研究,纳入2017至2023年一家多学科头颈癌生存门诊中所有接受手术治疗的恶性腮腺肿瘤患者,共62例。
  • 患者报告结局指标包括华盛顿大学生活质量问卷(UW-QOL)、进食评估工具(EAT-10)、患者健康问卷(PHQ-8)、广泛性焦虑障碍量表(GAD-7)、颈部功能障碍指数(NDI)和失眠严重指数。
  • 采用多变量回归分析探究与患者报告结局相关的临床预测因素。

主要发现

  • 62例恶性腮腺肿瘤患者末次随访时,临床相关吞咽困难症状(EAT-10)患病率为32.3%,抑郁症状升高(PHQ-8)为15.5%,中重度焦虑症状(GAD-7)为7.1%,中重度颈痛影响日常生活活动(NDI)为17.7%,中重度失眠症状为7.2%。
  • 非参数单侧检验显示,辅助放化疗患者较单纯手术患者的躯体生活质量、社会情绪生活质量和吞咽评分显著更差(p=0.01、p=0.02、p=0.03)。
  • 辅助放疗患者较单纯手术患者的躯体生活质量和社会情绪生活质量显著更差(p<0.01、p=0.01)。
  • 辅助放化疗患者较辅助放疗患者的吞咽和颈痛显著更差(p=0.03、p=0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study describes patient-reported outcome measures (PROMs) and associated factors in patients who underwent surgery for malignant parotid tumors (MPT). METHODS: This is a retrospective study of all surgically treated MPT patients in a multidisciplinary head and neck cancer (HNC) survivorship clinic (2017-2023). PROMs included University of Washington Quality of Life Questionnaire (UW-QOL), Eating Assessment Tool (EAT-10), Patient Health Questionnaire (PHQ-8), Generalized Anxiety Disorder (GAD-7), Neck Disability Index (NDI), and Insomnia Severity Index. Multivariable regression analysis was used to investigate clinical predictors associated with PROMs. RESULTS: In 62 MPT patients, the prevalence of clinically relevant dysphagia symptoms (EAT-10), elevated symptoms of depression (PHQ-8), moderate/severe symptoms of anxiety (GAD-7), moderate/severe neck pain with activities of daily living (NDI), and moderate/severe symptoms of insomnia at last follow-up was 32.3%, 15.5%, 7.1%, 17.7%, and 7.2%, respectively. Nonparametric one-sided test revealed that patients treated with adjuvant CRT had significantly worse physical QOL, social-emotional QOL, and swallowing scores than patients treated with surgery alone (p = 0.01, p = 0.02, p = 0.03, respectively); that patients treated with surgery and adjuvant RT had significantly worse physical QOL and social-emotional QOL than patients treated with surgery alone (p < 0.01, p = 0.01, respectively) and that patients treated with surgery and adjuvant CRT had significantly worse swallowing and neck pain than patients treated with surgery and adjuvant RT (p = 0.03, p = 0.05, respectively). CONCLUSIONS: In patients with surgically treated MPT, adjuvant CRT and RT were associated with worse PROMs. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:4549-4556, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Tang A, Li J, Scheff N, et al. Quality of Life Outcomes for Parotid Malignancies. Laryngoscope. 2024. PMID: 38837232. doi:10.1002/lary.31554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。